Your browser doesn't support javascript.
loading
Metabolites as Risk Factors for Diabetic Retinopathy in Patients With Type 2 Diabetes: A 12-Year Follow-up Study.
Fernandes Silva, Lilian; Hokkanen, Jenna; Vangipurapu, Jagadish; Oravilahti, Anniina; Laakso, Markku.
Affiliation
  • Fernandes Silva L; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
  • Hokkanen J; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
  • Vangipurapu J; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
  • Oravilahti A; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
  • Laakso M; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
J Clin Endocrinol Metab ; 109(1): 100-106, 2023 Dec 21.
Article in En | MEDLINE | ID: mdl-37560996
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Diabetic Retinopathy Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Endocrinol Metab Year: 2023 Document type: Article Affiliation country: Finland Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Diabetic Retinopathy Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Endocrinol Metab Year: 2023 Document type: Article Affiliation country: Finland Country of publication: United States